On average, obesity is associated with 4.7 years of life lost per affected individual and has been estimated to reduce overall U.S
April 16, 2026: Ozempic & GLP-1 MDL Passes 3,500 Cases The number of lawsuits in a federal MDL alleging severe gastrointestinal side effects from taking GLP-1s like Ozempic has climbed to 3,546
This means the agency does not review compounded drugs for safety, effectiveness or quality before they are marketed. The Obesity Action Coalition (OAC), The Obesity Society (TOS), and The Obesity Medicine Association (OMA) have released a statement expressing their concerns for patients using the compounded GLP-1 alternatives
Commonly Reported Effects The most frequently mentioned experiences during BPC-157 use include mild injection site reactions such as redness, minor swelling, or temporary discomfort
This is also the phase where researchers need to be most vigilant about nutritional supplementation